SMi is proud to present their inaugural ADC Summit. This new and exciting event will present attendees with an in-depth view into novel innovations, developments and utilities of antibody-drug conjugates. The 2012 speaker line up, with key experts from all sectors of the industry will provide attendees with a unique insight into latest technological and scientific developments and will be the perfect platform for debate and problem-solving discussion.

Key benefits of attending:
• Learn about and consider solutions to the issues within the current ADC pipeline from companies such as Seattle Genetics and Immunogen
• Evaluate Genentech’s and GSK’s innovative strategies to ensure success in payload delivery
• Hear about manufacturing developments from the FDA, Pfizer and Agensys
• Consider novel linker strategy techniques to increase efficacy of ADC products
• Discuss the most important factors in developing a successful antibody-drug conjugate
• Understand from case studies the key challenges in ADC design
• Network with key industry professionals

Visit our website here: http://www.smi-online.co.uk/adcsummit10.asp

Alternatively contact Fateja Begum on: +44 (0) 20 7827 6184 e-mail: fbegum@smi-online.co.uk
Quote “Select Science” to save £100